Anxiety Disorders    Bipolar Disorder    Dementia    Depression    Epilepsy    Migraine    Multiple Sclerosis    OCD    Panic Disorder  
  Parkinson's Disease    PTSD    Schizophrenia    Sleep Disorders    Stroke  
 

More maps of the brain
    Forebrain
    Midbrain
    Hindbrain
    Spinal cord
    Lobes
    Limbic system
    Coronal section
    Cerebral vasculature

 

PTSD

References

Brady KT. Post-traumatic stress disorder post-traumatic stress disorderand comorbidity: recognising the many faces of PTSD. J Clin Psychiatry 1997; 58 (Suppl 9): 12–15.

Braun P, Greenberg D, Daaberg H, Lerer B. Core symptoms of post-traumatic stress disorder unimproved by alprazolam. J Clin Psychiatry 1990; 51: 236–238.


Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and post-traumatic stress disorder in the community: the 1996 Detroit area survey of trauma. Arch Gen Psychiatry 1998; 55: 626–632.


Charney DS, Deutsch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of post-traumatic stress disorder. Arch Gen Psychiatry 1993; 50: 295–305.


Davidson JRT. Biological therapies for post-traumatic stress disorder: an overview. J Clin Psychiatry 1997; 58 (Suppl 9): 29–32.


Davidson JRT, Roth S, Newman E. Fluoxetine in post-traumatic stress disorder. J Trauma Stress 1991; 4: 419–423.


Davidson JRT, Weisler RH, Malik MH, Connor MK. Treatment of post-traumatic stress disorder with nefazodone. Int Clin Psychopharmacol 1998; 13: 111–113.

Davis LL, Suris A, Lambert MT, Heimberg C, Petty F. Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci 1997; 22: 318–326.

De Boer M, Op den Velde W, Falger RJR et al. Fluvoxamine treatment of chronic PTSD. Psychother Psychosom 1991; 57: 158–163.

Dow B, Kline N. Antidepressant treatment of post-traumatic stress disorder and major depression in veterans. Ann Clin Psychiatry 1997; 9: 1–5.

Ebbinghaus R, Bauer M, Priebe S. Behandlung der posttraumatischen Belastungsstorung. Fortschr Neurol Psychiatr 1996; 64: 433–443.

Foa EB, Olasov Rothbaum B, Riggs DS, Murdock TB. Treatment of post-traumatic stress disorder in rape victims: a comparison between cognitive-behavioural procedures and counselling. J Consult Clin Psychol 1991; 59: 715–723.

Helzer JE, Robins LN, McEvoy L. Post-traumatic stress disorder in the general population. Findings of the epidemiological catchment area survey. N Engl J Med 1987; 317: 1630–1634.

Hensman R, Guimaraes FS, Wang M, Deakin JFW. Effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology 1991; 104: 220–224.

Hertzberg MA, Feldman ME, Beckham JC, Davidson JR. Trial of trazodone for post-traumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996; 16: 294–298.

Joseph MH, Kennell GA. Corticosteroid response to stress depends upon increased tryptophan availability. Psychopharmacology 1983; 79: 79–81.

Kline NA, Dow BM, Brown SA, Matloff JA. Sertraline efficacy in depressed combat veterans with post-traumatic stress disorder. Am J Psychiatry 1994; 151: 621.

Kulka RA, Schlenger WE, Fairbank JA et al. Trauma and the Vietnam War generation: report of the findings of the National Vitnam Veterans’ Readjustment study. New York, NY: Brunner/Mazel, 1990.

Marmar CR, Schoenfield F, Weiss D et al. Open trial of fluvoxamine treatment for combat-related post-traumatic stress disorder. J Clin Psychiatry 1996; 14: 79–81.

Marshall RD, Stein DJ, Liebowitz MR, Yehuda R. A pharmacotherapy algorithm in the treatment of post-traumatic stress disorder. Psychiatry Ann 1996; 26: 217–226.

McDougle CJ, Southwick SM, Charney DS, St. James RI. An open clinical trial of fluoxetine in the treatment of post-traumatic stress disorder. J Clin Psychopharmacol 1991; 11: 325–327.

Nagy LM, Morgan CA, Southwick SM, Charney DS. Open prospective trial of fluoxetine for post-traumatic stress disorder. J Clin Psychopharmacol 1993; 13: 107–114.

Penava SJ, Otto MW, Pollack MH, Rosenbaum JF. Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies. Depress Anxiety 1996–97; 4: 240–242.

Rauch SL, Shin LM, Whalen PJ, Pitman RK. Neuroimaging and the neuroanatomy of post-traumatic stress disorder. CNS Spectrums 1998; 7S: 30–41.

Rothbaum RO, Foa EB, Rigge DS, Murdoch T, Walsh W. A prospective examination of post-traumatic stress disorder in rape victims. J Trauma Stress 1992; 5: 455–475.

Rothbaum BO, Ninan PT, Thomas L. Sertraline in the treatment of rape victims with post-traumatic stress disorder. J Trauma Stress 1996; 9: 865–871.

Shay J. Fluoxetine reduces explosiveness and elevates mood of Vietnam combat veterans with PTSD. J Trauma Stress 1992; 5: 97–101.

Solomon SD, Davidson JRT. Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry 1997; 58S: 5–11.

Solomon SD, Gerrity ET, Muff AM. Efficacy of treatments for post-traumatic stress disorder: an empirical review. JAMA 1992; 268: 633–638.

Southwick SM, Yehuda R, Morgan CA III. Clinical studies of neurotransmitter alterations in post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiology and clinical consequences of stress: from normal adaptation to PTSD. New York, NY: Lippincott-Raven, 1995: 335–349.

van der Kolk BA. The psychobiology of post-traumatic stress disorder. J Clin Psychiatry 1997; 58S: 16–24.

van der Kolk BA, Dreyfuss D, Michaels M et al. Fluoxetine in post-traumatic stress disorder. J Clin Psychiatry 1994; 55: 517–522.

Yehuda R. Recent developments in the neuroendocrinology of post-traumatic stress disorder. CNS Spectrums 1998; 7S: 22–29.

Yehuda R, McFarlane AC. Conflict between current knowledge about post-traumatic stress disorder and its original conceptual basis. Am J Psychiatry 1995; 152: 1705–1713.

 

 

 

 

   Feedback       Site map        Help        Home        Editorial board